After taking GLP-1 weight-loss drugs and finally shedding those excess pounds, some had gone a bit rogue
The overall heterogeneity for MACE was low (I 2 = 15.3%, 95% uncertainty intervals, 0 and 52.3%) (Table S3)
There are three GLP-1 drugs that the FDA has approved for the treatment of obesity: Zepbound (tirzepatide), Saxenda (liraglutide), and Wegovy (semaglutide)
Eating small, frequent meals and staying hydrated can reduce nausea duration by 3040% compared to patients who don't adjust their diet
Whilst you are tapering off, you should monitor your weight and appetite closely and ensure you keep up with your healthy eating and exercise habits
The reduction in injection frequency was led by the individuals, with 24 participants reporting a minimum of 2 weeks between injections